Abstract
Impaired metabolism of α-synuclein (SNCA) and its aggregation are key molecular events underlying Parkinson’s disease (PD). Emerging data show that there is a connection between PD and the gene locus containing the SNCA gene. Meta-analyses have demonstrated a highly significant PD connection with single nucleotide polymorphisms (SNPs) rs356165 (A/G) and rs356219 (A/G) in the SNCA gene. We conducted SNP genotyping in 260 PD patients (n = 260) and 262 healthy people (n = 262) from northwestern regions of Russia. Linkage disequilibrium was registered between rs356219 and rs356165 alleles (D' = 0.926). It was confirmed that G alleles (rs356165 and rs356219) are associated with increased risk of PD development. For the first time, we have evaluated the relationship between rs356165 and rs356219 and levels of SNCA mRNA and α-synuclein protein in CD45+ peripheral blood cells in drug-naïve PD patients (n = 43) and controls (n = 39). Both the level of mRNA SNCA gene and that of α-synuclein protein were increased in carriers of rs356219 and rs356165 compared to carriers with AA genotype in control group (in the group of healthy people) (p = 0.046 and p = 0.039, respectively). Linkage disequilibrium was shown between associated marker alleles. Our data suggest that rs356165 and rs356219 allele variants may affect the PD development by up-regulation of SNCA expression.
Similar content being viewed by others
Abbreviations
- PD:
-
Parkinson’s disease
- IEA:
-
immunoenzyme assay
- mRNA:
-
messenger RNA
- miRNA:
-
microRNA
- SNP:
-
single nucleotide polymorphism
- PAG:
-
polyacrylamide gel
- GWAS:
-
genome-wide association studies
References
Blandini, F., Sinforiani, E., Pacchetti, C., Samuele, A., Bazzini, E., Zangaglia, R., Nappi, G., and Martignoni, E., Peripheral proteasome and caspase activity in Parkinson disease and Alzheimer disease, Neurology, 2006, vol. 66, pp. 529–534.
Böyum, A., Isolation of leucocytes from human blood. Further observations. Methylcellulose, dextran, and ficoll as erythrocyte aggregating agents, Scand. J. Clin. Lab. Invest. Suppl., 1968a, vol. 97, pp. 31–50.
Böyum, A., Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g, Scand. J. Clin. Lab. Invest. Suppl., 1968b, vol. 97, pp. 31–50.
Cardo, L.F., Coto, E., de Mena, L., Ribacoba, R., Lorenzo-Betancor, O., Pastor, P., Samaranch, L., Mata, I.F., Díaz, M., Moris, G., Menéndez, M., Corao, A.I., and Alvarez, V., A search for SNCA 3' UTR variants identified SNP rs356165 as a determinant of disease risk and onset age in Parkinson’s disease, J. Mol. Neurosci., 2012, vol. 47, pp. 425–430.
Chiba-Falek, O. and Nussbaum, R.L., Effect of allelic variation at the NACP-Rep1 repeat upstream of the alphasynuclein gene (SNCA) on transcription in a cell culture luciferase reporter system, Hum. Mol. Genet., 2001, vol. 10, pp. 3101–3109.
Devine M.J., Gwinn, K., Singleton, A., and Hardy, J., Parkinson’s disease and α-Synuclein expression, Mov. Disord., 2011, vol. 26, pp. 2160–2168.
Doxakis, E., Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153, J. Biol. Chem., 2010, vol. 285, pp. 12726–12734.
Edwards, T.L., Scott, W.K., Almonte, C., Burt, A., Powell, E.H., Beecham, G.W., Wang, L., Züchner, S., Konidari, I., Wang, G., Singer, C., Nahab, F., Scott, B., Stajich, J.M., Pericak-Vance, M., Haines, J., Vance, J.M., and Martin, E.R., Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson’s disease, Ann. Hum. Genet., 2010, vol. 74, pp. 97–109.
Eller, M., and Williams, D.R., α-Synuclein in Parkinson Disease and Other Neurodegenerative Disorders, Clin. Chem. Lab. Med., 2011, vol. 49, pp. 403–408.
Emelyanov A., Andoskin, P., Yakimovskii, A., Usenko, T., Nuzhnyi, E., Nikolaev, M., and Pchelina, S., SNCA, LRRK2, MAPT polymorphisms and Parkinson’s disease in Russia, Parkinsonism Relat. Disord., 2013, vol. 19, pp. 1064–1065.
Fuchs, J., Tichopad, A., Golub, Y., Munz, M., Schweitzer, K.J., Wolf, B., Berg, D., Mueller, J.C., and Gasser, T., Genetic variability in the SNCA gene influences alpha-synuclein levels in the blood and brain, J. FASEB, 2008, vol. 22, pp. 1327–1334.
Giráldez-Pérez, R., Antolín-Vallespín, M., Muñoz, M., and Sánchez-Capelo, A., Models of α-Synuclein aggregation in Parkinson’s disease, Acta Neuropathol. Commun., 2014, vol. 2, p. 176.
Han, W., Yingjun, M., Jing, Z., Dianwu, L., and Quingbao, T., Alpha-synuclein (SNCA) polymorphisms and susceptibility to Parkinson’s disease: a meta-analysis, Am. J. Med. Genet. Part B, 2014, vol. 9999, pp. 1–12.
Hong, Z., Shi, M., Chung, K.A., Quinn, J.F., Peskind, E.R., Galasko, D., Jankovic, J., Zabetian, C.P., Leverenz, J.B., Baird, G., Montine, T.J., Hancock, A.M., Hwang, H., Pan, C., Bradner, J., Kang, U.J., Jensen, P.H., and Zhang, J., DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease, Brain, 2010, vol. 133, pp. 713–726.
Hu, Y., Tang, B., Guo, J., Wu, X., Sun, Q., Shi, C., Hu, L., Wang, C., Wang, L., Tan, L., Shen, L., Yan, X., and Zhang, H., Variant in the 3' region of SNCA associated with Parkinson’s disease and serum α-Synuclein levels, J. Neurol., 2012, vol. 259, pp. 497–504.
Lill, C.M., Roehr, J.T., McQueen, M.B., Kavvoura, F.K., Bagade, S., Schjeide, B.M., Schjeide, L.M., Meissner, E., Zauft, U., Allen, N.C., Liu, T., Schilling, M., Anderson, K.J., Beecham, G., Berg, D., Biernacka, J.M., Brice, A., DeStefano, A.L., Do, C.B., Eriksson, N., Factor, S.A., Farrer, M.J., Foroud, T., Gasser, T., Hamza, T., Hardy, J.A., Heutink, P., Hill-Burns, E.M., Klein, C., Latourelle, J.C., Maraganore, D.M., Martin, E.R., Martinez, M., Myers, R.H., Nalls, M.A., Pankratz, N., Payami, H., Satake, W., Scott, W.K., Sharma, M., Singleton, A.B., Stefansson, K., Toda, T., Tung, J.Y., Vance, J., Wood, N.W., Zabetian, C.P.; Young, P., Tanzi, R.E., Khoury, M.J., Zipp, F., Lehrach, H., Ioannidis, J.P., and Bertram, L., Comprehensive research synopsis and systematic metaanalyses in Parkinson’s disease genetics: the PDGene Database, PLoS Genet., 2012, vol. 8, p. e1002548.
Maraganore, D.M., de Andrade, M., Elbaz, A., Farrer,M.J., Ioannidis, J.P., Krüger, R., Rocca, W.A., Schneider, N.K., Lesnick, T.G., Lincoln, S.J., Hulihan, M.M., Aasly, J.O., Ashizawa, T., Chartier-Harlin, M.-C., Checkoway, H., Ferrarese, C., Hadjigeorgiou, G., Hattori, N., Kawakami, H., Lambert, J.-C., Lynch, T., Mellick, G.D, Papapetropoulos, S., Parsian, A., Quattrone, A., Riess, O., Tan, E.-K., and Broeckhoven, C.V., Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson’s disease, J. Am. Med. Assoc., 2006, vol. 296, pp. 661–670.
Mata I.F., Shi, M., Agarwal, P., Chung, K.A., Edwards, K.L., Factor, S.A., Galasko, D.R., Ginghina, C., Griffith, A., Higgins, D.S., Kay, D.M., Kim, H., Leverenz, J.B., Quinn, J.F., Roberts, J.W., Samii, A., Snapinn, K.W., Tsuang, D.W., Yearout, D., Zhang, J., Payami, H., and Zabetian, C.P., SNCA variant associated with Parkinson disease and plasma alpha-synuclein level, Arch. Neurol., 2010, vol. 67, pp. 1350–1356.
Miller, D.W., Hague, S.M., Clarimon, J., Baptista, M., Gwinn-Hardy, K., Cookson, M.R., and Singleton, A.B., Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication, Neurology, 2004, vol. 62, pp. 1835–1838.
Mizuta, I., Takafuji, K., Ando, Y., Satake, W., Kanagawa, M., Kobayashi, K., Nagamori, S., Shinohara, T., Ito, C., Yamamoto, M., Hattori, N., Murata, M., Kanai, Y., Murayama, S., Nakagawa, M., and Toda, T., YY1 binds to α-Synuclein 3'-flanking region SNP and stimulates antisense noncoding RNA expression, J. Hum. Genet., 2013, vol. 58, pp. 711–719.
Myhre, R., Toft, M., Kachergus, J., Hulihan, M.M., Aasly, J.O., Klungland, H., and Farrer, M.J., Multiple alpha-synuclein gene polymorphisms are associated with Parkinson’s disease in a Norwegian population, Acta Neurol. Scand., 2008, vol. 118, pp. 320–327.
Nalls, M.A., Pankratz, N., Lill, C.M., Do, C.B., Hernandez, D.G., Saad, M., DeStefano, A.L., Kara, E., Bras, J., Sharma, M., Schulte, C., Keller, M.F., Arepalli, S., Letson, C., Edsall, C., Stefansson, H., Liu, X., Pliner, H., Lee, J.H., Cheng, R.; Ikram, M.A., Ioannidis, J.P., Hadjigeorgiou, G.M., Bis, J.C., Martinez, M., Perlmutter, J.S., Goate, A., Marder, K., Fiske, B., Sutherland, M., Xiromerisiou, G., Myers, R.H., Clark, L.N., Stefansson, K., Hardy, J.A., Heutink, P., Chen, H., Wood, N.W., Houlden, H., Payami, H., Brice, A., Scott, W.K., Gasser, T., Bertram, L., Eriksson, N., Foroud, T., and Singleton, A.B., Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease, Nat. Genet., 2014, vol. 46, pp. 989–993.
Pankratz, N., Wilk, J.B., Latourelle, J.C., DeStefano, A.L., Halter, C., Pugh, E.W., Doheny, K.F., Gusella, J.F., Nichols, W.C., Foroud, T., and Myers, R.H; PSG-PROGENI and GenePD Investigators, Coordinators and Molecular Genetic Laboratories. Genome-wide association study for susceptibility genes contributing to familial Parkinson disease, Hum. Genet., 2009, vol. 124, p. 593e605.
Pellicano, C., Buttarelli, F.R., Circella, A., Tiple, D., Giovannelli, M., Benincasa, D., Colosimo, C., and Pontieri, F.E., Dopamine transporter immunoreactivity in peripheral blood lymphocytes discriminates Parkinson’s disease from essential tremor, J. Neural Transm., 2007, vol. 114, pp. 935–938.
Ritz B., Rhodes, S.L., Bordelon, Y., and Bronstein, J., α-Synuclein genetic variants predict faster motor symptom progression in idiopathic Parkinson disease, PLoS One, 2012, vol. 7, p. e36199.
Ross O.A., Gosal, D., Stone, J.T., Lincoln, S.J., Heckman, M.G., Irvine, G.B., Johnston, J.A., Gibson, J.M., Farrer, M.J., and Lynch, T., Familial genes in sporadic disease: common variants of alpha-synuclein gene associate with Parkinson’s disease, Mech. Ageing Dev., 2007, vol. 128, pp. 378–382.
Schmitt, I., Kaut, O., Khazneh, H., deBoni, L., Ahmad, A., Berg, D., Klein, C., Fröhlich, H., and Wüllner, U., L-DOPA increases a -synuclein DNA methylation in Parkinson’s disease patients in vivo and in vitro, Mov. Disord., 2015, vol. 14.doi 10.1002/mds.26319
Sellbach A.N., Boyle, R.S., Silburn, P.A., and Mellick, G.D., Parkinson’s disease and family history, Parkinsonism Relat. Disord., 2006, vol. 12, pp. 399–409.
Shi, M., Bradner, J., Hancock, A.M., Chung, K.A., Quinn, J.F., Peskind, E.R., Galasko, D., Jankovic, J., Zabetian, C.P., Kim, H.M., Leverenz, J.B., Montine, T.J., Ginghina, C., Kang, U.J., Cain, K.C., Wang, Y., Aasly, J., Goldstein, D., and Zhang, J., Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression, Ann. Neurol., 2011, vol. 69, pp. 570–580.
Singleton, A.B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., Lincoln, S., Crawley, A., Hanson, M., Maraganore, D., Adler, C., Cookson, M.R., Muenter, M., Baptista, M., Miller, D., Blancato, J., Hardy, J., and Gwinn-Hardy, K., Alpha-synuclein locus triplication causes Parkinson’s disease, Science, 2003, vol. 302, p. 841.
Sotiriou, S., Gibney, G., Baxevanis, A.D., and Nussbaum, R.L., A single nucleotide polymorphism in the 3'UTR of the SNCA gene encoding alpha-synuclein is a new potential susceptibility locus for Parkinson disease, Neurosci. Lett., 2009, vol. 461, pp. 196–201.
Venda L.L., Cragg, S.J., Buchman, V.L., and Wade-Martins, R., α-Synuclein and dopamine at the crossroads of Parkinson’s disease, Trends Neurosci., 2010, vol. 33, pp. 559–568.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © A.K. Emelyanov, P.A. Andoskin, I.V. Miliukhina, A.A. Timofeeva, A.F. Yakimovskii, K.A. Senkevich, M.A. Nikolaev, S.N. Pchelina, 2016, published in Tsitologiya, 2016, Vol. 58, No. 2, pp. 99–104.
Rights and permissions
About this article
Cite this article
Emelyanov, A.K., Andoskin, P.A., Miliukhina, I.V. et al. SNCA alleles rs356219 and rs356165 are associated with Parkinson’s disease and increased α-synuclein gene expression in CD45+ blood cells. Cell Tiss. Biol. 10, 277–283 (2016). https://doi.org/10.1134/S1990519X16040064
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1990519X16040064